Cincinnati Children’s international collaborative to fund three pediatric medical device projects

A recently launched partnership between Cincinnati Children’s Hospital Medical Center and Ben-Gurion University in Israel is funding the research and development of three pediatric-specific medical devices.

The collaboration, which pairs the medical expertise of CCHMC physicians with the technical and engineering capabilities of BGU, started with nearly 80 unaddressed problems facing surgeons and physicians. After reviewing these ideas and proposed solutions, 10 projects underwent rigorous application cycles, thorough market analyses and review by internal and external stakeholders.

The initial three projects that will be funded—a smart sensing catheter, a surfactant-delivery device, and an image-guided needle insertion device—have potential to not only improve patient care and outcomes, but also reduce costs to the healthcare system.

“The pediatric market, especially with regard to medical devices, has historically been neglected primarily due to prohibitive development costs,” said Niki Robinson, assistant vice president of CCHMC’s Center for Technology Commercialization. “This initiative presents an unprecedented opportunity for early stage ideas to receive funding and move through a development plan backed by world-class physicians and engineers.”

The smart sensing catheter concept was developed by Richard Azizkhan, MD, surgeon-in-chief at CCHMC and the Lester W. Martin Chair of Pediatric Surgery, and Ibrahim Abdulhalim, professor of electro-optical engineering at BGU. The device provides immediate and continuous assessment of the metabolic and physiological profile of critically ill infants and small children. “Secondarily, this technology will reduce the need for repeated tests, thus reducing costs for the health system and society,” said Azizkhan.

The surfactant delivery device concept was developed by Jeffrey Whitsett, MD, co-director, Perinatal Institute and chief, section of neonatology, perinatal and pulmonary biology at CCHMC, and Joseph Kost, dean of the faculty of engineering sciences and professor of biomedical engineering at BGU. It consists of a delivery system for prolonged administration of surfactants to the lungs of premature babies using nanoparticles. Current procedures do not allow for the sustained release of proteins or other complex particles in the alveoli of infants or adults.

Daniel von Allmen, MD, director, Division of General and Thoracic Surgery at CCHMC, and Hugo Guterman, professor of electrical and computer engineering at BGU are collaborating on the image guided needle insertion device concept. It combines sophisticated new imaging techniques with the precision of robotics to improve the accuracy of many procedures.

Each project will receive up to $100,000 in the first round, with all funding contingent upon achieving project-specific developmental milestones.

Speaking to the value of early stage investment in research, von Allmen said, “One of the enormous struggles for physicians, many of whom are very experienced in their fields and knowledgeable about challenges to care, is the ability to get an idea from the back of a napkin in the cafeteria to a coordinated development effort. Cincinnati Children’s has put a lot of resources into creating the infrastructure to make the translation of good ideas to products a reality.”

Cincinnati-based seed-stage investor CincyTech and Israel-based Ridgeback Business Development helped evaluate the projects.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Cardinal Health and Henry Schein long-term agreement to serve physician offices, Cardinal’s physician office-focused organization consolidated into Henry Schein’s Medical Group | Cardinal Health, November 21, 2014

Navidea’s Lymphoseek approved for sale in Europe | Columbus Business First, November 20, 2014

Codonics honored by Frost & Sullivan for enhancing patient safety and accuracy of medication management with the Safe Label System | Frost & Sullivan, November 20, 2014

Microbial Robotics’ new genetics rights management product platform enters international markets with patent filing | PR Newswire, November 19, 2014

Matrix Medical Devices of Cleveland purchases Mentor-based REU Associates | Crains Cleveland Business, November 19, 2014

Global Emerging Pathogen Treatment Consortium formed to study potential of immune plasma treatment in the fight against Ebola, ClinicalRM, USAMRIID | PR Newswire, November 19, 2014

Freedom Meditech granted key U.S. patent covering the ClearPath DS-120 device and method of use | PR Newswire, November 19, 2014

New Ricerca CEO remains positive as questions linger over company | Outsourcing Pharma, November 19, 2014

Cleveland Clinic and Parker Hannifin developing hundreds of potential medical advancments | MedCity News, November 18, 2014

Ohio State University Comprehensive Cancer Center researcher wins supercomputing award for cancer research | Ohio Supercomputer Center, November 18, 2014

CTI Clinical Trial and Consulting Services opens office in Belgium, their sixth new location this year | Cincinnati Business Courier, November 18, 2014

Successful “Date Certain M&A” of AxioMed Spine Corp. its assets and intellectual property | Gerbsman Partners, November 18, 2014

889 Global Solutions profiled by WOSU Career Connections Series (video) | WOSU Public Media via YouTube, November 18, 2014

Duke University Hospital using technology from Dayton-area firm, Riverain Technologies | Dayton Business Journal, November 18, 2014

Ricerca Biosciences acquired by Main Market Partners, a growth-oriented equity investment group | PR Newswire, November 18, 2014

STATKING Clinical Services celebrates 25 years serving the pharmaceutical and medical device industry | BioOhio, November 18, 2014

EnzymeBioSystems announces an independent research group reported breast cancer preventive efficacy for a novel synthetic triterpenoid | PR Newswire, November 17, 2014

Summa Health System names Dr. Thomas Malone as new CEO | Cleveland.com, November 17, 2014

Invacare announces retirement of Joseph Richey, President Technologies Division, Sr VP Electronic and Design Engineering | Business Wire, November 17, 2014

Ohio doctor’s method could reduce breast cancer treatment risks, University of Toledo, ProMedica Health | Toledo Free Press, November 15, 2014